INTZ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
INTZ is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The pre-market move is modestly positive, but the broader setup is weak: analyst sentiment is only Neutral with a lowered price target, there is no fresh news catalyst, no strong proprietary trading signal, and the technical picture is mixed rather than decisively bullish. For an impatient buyer who does not want to wait for an ideal entry, this is still not a strong enough setup to justify buying now.
INTZ is trading pre-market at 0.818, up 3.06%, but the technicals do not confirm a strong trend. MACD histogram is slightly positive at 0.00759 but is contracting, which suggests weakening momentum. RSI_6 at 48.952 is neutral, showing no clear overbought or oversold signal. Moving averages are converging, pointing to a range-bound or indecisive structure rather than a confirmed breakout. Key levels are pivot 0.813, resistance at 0.878 and 0.918, and support at 0.748 and 0.708. The short-term pattern data also leans cautious, with a 60% chance of -1.78% next day and -0.76% next week, while the one-month outlook is only mildly positive at 2.78%.
The only near-term positive factor is the pre-market price strength, which is slightly above the pivot level. The stock pattern analysis suggests a possible modest rebound over the next month, and there is no immediate negative news flow in the last week.
Analyst sentiment is neutral and the price target was cut from $2 to $1, reflecting reduced expectations. The company also reported a Q4 revenue miss tied to a contract funding delay, which hurt sentiment. There was no recent news flow to support a fresh rerating, hedge funds were neutral, insiders were neutral, and there is no recent congress trading activity to suggest notable outside interest.
No usable latest-quarter financial snapshot was provided because of an error, so there is not enough financial detail to assess recent revenue or earnings growth directly. The only financial detail available is the analyst note that referenced a Q4 revenue miss caused by a contract funding delay, which suggests temporary operational pressure rather than clear growth acceleration. Latest quarter season referenced: Q4.
Wall Street view is mixed to cautious. H.C. Wainwright lowered its price target on Intrusion to $1 from $2 while keeping a Neutral rating after a Q4 revenue miss caused by a contract funding delay. Pros: the setback was described as temporary, and the reduced target still implies some upside from very low levels. Cons: the Neutral rating, lower target, and lack of fresh catalysts show pros do not have a strong bullish view on the stock right now.
